Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Highlights • The automated immunoassays showed a higher sensitivity than the ELISA based assays.• The assay using the S and N protein as antigens showed the highest sensitivity.• There were differences in the immune response (targeting SARS-CoV-2 S/N antigen).• The titers generated with the examined assays correlated well with the PRNT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360 · cited 1×
“Besides humoral mediated immunity, there is evidence that T-cell mediated immunity plays a role [7].”
BackgroundOu, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097 · cited 1×
“The spike (S) protein of SARS-CoV-2 has shown to be highly immunogenic and is the main target for neutralizing antibodies [4].”
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Zheng, S., Fan, J., Yu, F., Feng, B., Lou, B., Zou, Q., Xie, G., Lin, S., Wang, R., Yang, X., et al. (2020) · BMJ · doi:10.1136/bmj.m1443 · Cited by 1,440 · cited 1×
“However, for epidemiological studies, in determining the seroprevalence of SARS-CoV-2 in the general population or in special collectives there is an increasing demand in the detection of antibodies – especially of IgG antibodies [2].”
BackgroundSARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
Rabi, F. A., Al Zoubi, M. S., Kasasbeh, G. A., Salameh, D. M., & Al-Nasser, A. D. (2020) · Pathogens · doi:10.3390/pathogens9030231 · Cited by 775 · cited 1×
“Nucleic acid amplification testing (NAT) is the method of choice in the early phase of infection [1].”
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019
Xiang, F., Wang, X., He, X., Peng, Z., Yang, B., Zhang, J., Zhou, Q., Ye, H., Ma, Y., Li, H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa461 · Cited by 535 · cited 1×
“higher sensitivity a couple of weeks after infection [5,6].”
Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review
Rajendran, K., Krishnasamy, N., Rangarajan, J., Rathinam, J., Natarajan, M., & Ramachandran, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25961 · Cited by 360 · cited 1×
“Furthermore for therapeutic or prophylactic approaches, convalescent plasma may be used as vaccines and other drugs are under development [3].”
Profile of specific antibodies to SARS-CoV-2: The first report
Xiao, A. T., Gao, C., & Zhang, S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.012 · Cited by 245
Cited by
Diagnostics for SARS-CoV-2 infections
Kevadiya, B. D., Machhi, J., Herskovitz, J., Oleynikov, M. D., Blomberg, W. R., Bajwa, N., Soni, D., Das, S., Hasan, M., Patel, M., et al. (2021) · Nature Materials · doi:10.1038/s41563-020-00906-z · Cited by 833
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
Rabi, F. A., Al Zoubi, M. S., Kasasbeh, G. A., Salameh, D. M., & Al-Nasser, A. D. (2020) · Pathogens · doi:10.3390/pathogens9030231 · Cited by 775
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019
Xiang, F., Wang, X., He, X., Peng, Z., Yang, B., Zhang, J., Zhou, Q., Ye, H., Ma, Y., Li, H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa461 · Cited by 535
The first 12 months of COVID-19: a timeline of immunological insights
Carvalho, T., Krammer, F., & Iwasaki, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00522-1 · Cited by 443
Safiabadi Tali, S. H., LeBlanc, J. J., Sadiq, Z., Oyewunmi, O. D., Camargo, C., Nikpour, B., Armanfard, N., Sagan, S. M., & Jahanshahi-Anbuhi, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00228-20 · Cited by 405
Nicol, T., Lefeuvre, C., Serri, O., Pivert, A., Joubaud, F., Dubée, V., Kouatchet, A., Ducancelle, A., Lunel-Fabiani, F., & Le Guillou-Guillemette, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104511 · Cited by 218
“Few studies reported clinical performance of Abbott assay [14,16,26,28].”
Oved, K., Olmer, L., Shemer-Avni, Y., Wolf, T., Supino-Rosin, L., Prajgrod, G., Shenhar, Y., Payorsky, I., Cohen, Y., Kohn, Y., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100651 · Cited by 129
“The 588 samples obtained 14 days after first positive PCR allowed evaluation of the true sensitivity of the different kits in comparison to other studies examining specific assays and smaller cohorts [3, 4].”
(2022) · doi:10.1016/j.ebiom.2022.104042 · Cited by 87
Metadata
- Authors
- Kohmer, N., Westhaus, S., Rühl, C., Ciesek, S., & Rabenau, H. F.
- Venue
- Journal of Clinical Virology
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 129
- Pages
- 104480
- ISSN
- 1386-6532 (ISSN-L)
- OpenAlex
- W3028783641
- Cited by
- 187
- References
- 9
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.